1. A6.14 Dysregulations in the sphingolipid pathway in sle patients. (24th February 2016) Authors: Checa, A; Idborg, H; Sar, D Garcia; Jakobsson, PJ; Wheelock, CE; Gunnarsson, I Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adipose tissue derived ceramides regulate myocardial redox state and predict cardiovascular outcomes. (3rd October 2022) Authors: Polkinghorne, M; Akawi, N; Badi, I; Checa, A; Kotanidis, C; Akoumianakis, I; Antonopoulos, A; Krasopoulos, G; Sayeed, R; Walcot, N; Channon, K; Wheelock, C; Antoniades, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study. (September 2017) Authors: Checa, A; Idborg, H; Zandian, A; Sar, D Garcia; Surowiec, I; Trygg, J; Svenungsson, E; Jakobsson, P-J; Nilsson, P; Gunnarsson, I; Wheelock, C E Journal: Lupus Issue: Volume 26:Number 10(2017) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗